Product Name: Fosaprepitant dimeglumine
Chemical Name: (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentaol hemi((3-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonate)
SMILES Code: O=C(N1)N(P(O)(O)=O)N=C1CN2CCO[C@H](O[C@H](C)C3=CC(C(F)(F)F)=CC(C(F)(F)F)=C3)[C@@H]2C4=CC=C(F)C=C4.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)CNC.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)CNC
CAS NO: 1201913-82-7 Product: Pyridoclax
Synonym: MK0517; MK 0517; MK-0517
Chemical Formula: C37H56F7N6O16P
Appearance: Solid powderWeb Site：Medchemexpress
Purity: 98% (this data is for the first batch)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 8211; 4 C for short term (days to weeks) or -20 C for long term (months to years).CaSR inhibitors
Solubility: Soluble in DMSO, not in water
Background Description: Fosaprepitant dimeglumine (MK-0517) is a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved by the FDA on January PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/21430703
